C213157Level 6

Acalabrutinib/Bendamustine/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of acalabrutinib, bendamustine and rituximab that can be used for the treatment of mantle cell lymphoma (MCL).

**Synonyms:** - Acalabrutinib-Bendamustine-Rituximab - Acalabrutinib/Bendamustine/Rituximab - BR Plus Acalabrutinib - Bendamustine/Rituximab/Acalabrutinib - Calquence/Bendamustine/Rituxan

GET/api/v1/systems/nci_thesaurus/nodes/C213157

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue